Based in Alpharetta, Georgia, Virios Therapeutics is a biotech company focused on creating antiviral treatments for autoimmune diseases caused by viral triggers. One of its key treatments is IMC-1, a combination of famciclovir and celecoxib, which targets fibromyalgia. The company is also developing IMC-2 for managing the symptoms of long COVID.